Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Antibodies targeted against LOXL-2 for the treatment of collagen-associated pathologies

Antibodies targeted against LOXL-2 for the treatment of collagen-associated pathologies

US Patent 10040868 · Granted Aug 7, 2018

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compositions for remodeling extracellular matrix and methods of use thereof2025
Anti-matrix metalloproteinase 7 (MMP-7) inhibitory antibody and uses thereof2025
Compositions for remodeling extracellular matrix and methods of use thereof2023
Methods of preventing secondary infections2022
Compositions for remodeling extracellular matrix and methods of use thereof2022
Variants of TACE pro-domain as TNF-A inhibitor and their medical use2021
Compositions for remodeling extracellular matrix and methods of use thereof2020
Methods of preventing secondary infections2020
Variants of TACE pro-domain as TNF-A inhibitor and their medical use2019
Methods of generating antibodies to metalloenzymes2018
Methods of generating antibodies to metalloenzymes2018
Antibodies and pharmaceutical compositions containing same useful for inhibiting2018